The 2. NTSC Vienna – A successful continuation
Neurotrauma is a global medical problem that affects over 70 million people every year. Diagnoses and treatment standards are suboptimal in almost all countries worldwide, especially the detection and treatment of complications such as cognitive deficits, depressive symptoms or post-traumatic stress disorders.
In 2022, EVER Pharma supported the international medical society AMN (Academy of Multidisciplinary Neurotraumatology) in organizing the first training course of the Neurotrauma Simulation Centre Vienna (NTSC). Due to the great success, another course was held in April this year.
From April 17 to 21, multidisciplinary teams from six different countries – Azerbaijan, Bosnia, Korea, Thailand, Ukraine, Vietnam – came to Vienna to get to know the multidisciplinary treatment structures common in Austria and to identify gaps in their own therapeutic standards.
Ever Pharma will support implementation projects in these countries that contribute to improving treatment standards.
What is the NTSC Vienna
Outlook 2024
Ever Pharma will continue its collaboration with the AMN and will also facilitate the 3rd NTSC-Vienna in June 2024.
Vienna as the venue of next year’s AMN congress, which will take place from 7 to 8 June, allows the combination of both events, so that many experts in neurotrauma care can take advantage of the opportunity of the 3rd NTSC, which will take place immediately before the congress.
Ever Pharma will also support the AMN congress and welcomes you to Vienna in June 2024.
